Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain

Details for Australian Patent Application No. 2004285452 (hide)

Owner Merck & Co., Inc.

Inventors Pracitto, Richard; Gunzner, Janet; Lebsack, Alec D.; Venkatraman, Shankar; Munoz, Benito; Wang, Bowei

Agent Spruson & Ferguson

Pub. Number AU-A-2004285452

PCT Pub. Number WO2005/041971

Priority 60/513,046 21.10.03 US

Filing date 15 October 2004

Wipo publication date 12 May 2005

International Classifications

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

C07D 237/32 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 237/34 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/041971 Priority application(s): WO2005/041971

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285455-Therapeutic regimens for BAFF antagonists

2004285450-Zeolite molecular sieves for the removal of toxins